**Question:** Antiarrhythmic drugs not causing torsade de points are

A. Class Ia (e.g., lidocaine, procainamide)
B. Class Ic (e.g., flecainide, propafenone)
C. Class III (e.g., sotalol, dofetilide)
D. Class IV (e.g., diltiazem, verapamil)

**Correct Answer:** .

**Core Concept:**
Torsade de points is a rare but potentially lethal ventricular tachycardia characterized by a series of rapid, twisting waves on an electrocardiogram (ECG). It is caused by prolongation of the QT interval which leads to abnormal electrical activity in the ventricles. Torsade de points can result from medications that prolong the QT interval, and understanding which classes of antiarrhythmic drugs are less likely to cause this side effect is crucial for patient safety.

**Why the Correct Answer is Right:**
The correct answer, Class II drugs, are less likely to cause torsade de points compared to other classes due to their mechanism of action. Class II drugs, such as diltiazem and verapamil, are calcium channel blockers that primarily affect the sinoatrial (SA) node and atrioventricular (AV) node, slowing down the heart rate without significantly affecting the QT interval. In comparison, other classes of antiarrhythmic drugs prolong the QT interval and increase the risk of torsade de points.

**Why Each Wrong Option is Incorrect:**

A. Class Ia drugs, including lidocaine and procainamide, prolong the QT interval and are more likely to cause torsade de points. They act on sodium channels to block impulse conduction in the heart and are often used to treat supraventricular tachycardias.

B. Class Ic drugs, such as flecainide and propafenone, also prolong the QT interval and increase the risk of torsade de points. They target sodium channels, similar to Class Ia drugs, but have a more potent effect on the atrioventricular node, which may contribute to the QT interval prolongation.

C. Class III drugs, like sotalol and dofetilide, prolong the QT interval and increase the risk of torsade de points. They block the potassium channels, which can disrupt the normal repolarization of the ventricles and lead to QT prolongation.

D. Class IV drugs, like diltiazem and verapamil, also prolong the QT interval but are less likely to cause torsade de points compared to Class Ia, Ic, and III drugs. They act on calcium channels, blocking calcium influx into cardiac cells, which results in reduced force of contraction and heart rate. This mechanism helps prevent ventricular arrhythmias, but does not cause as significant QT interval prolongation as other classes, reducing the risk of torsade de points.

**Clinical Pearls:**
1. Understanding the mechanism of action and side effect profiles of different antiarrhythmic drugs is essential for